Discharge Medications Among Ischemic Stroke Survivors

Journal of Stroke and Cerebrovascular Diseases

Volumn 18, Issue 2, 2009, Pages 97-102

  Sweileh, Waleed M ^a   Sawalha, Ansam F ^a   Zyoud, Sa'ed H ^a   Al Jabi, Samah W ^a   Abaas, Majd A ^a  

^a AN NAJAH NATIONAL UNIVERSITY   (Palestine)

Author keywords

cost; ischemic; Medications; Palestine; stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIULCER AGENT; BETAHISTINE; BRONCHODILATING AGENT; CARBAMAZEPINE; CARDIOTONIC AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; ISOSORBIDE DINITRATE; LAXATIVE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PHENYTOIN; RANITIDINE; SEDATIVE AGENT; STEROID;

AGED; ANXIETY; ARTICLE; CEREBROVASCULAR ACCIDENT; COMBINATION CHEMOTHERAPY; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DRUG CLASSIFICATION; DRUG COST; FEMALE; GASTROINTESTINAL SYMPTOM; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; INFECTION COMPLICATION; ISCHEMIC HEART DISEASE; LIMB PAIN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MONOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SEIZURE; STROKE PATIENT; SURVIVOR; URINARY TRACT INFECTION; VERTIGO;

AGED; AMBULATORY CARE; ARABS; ASPIRIN; BRAIN ISCHEMIA; CAUSALITY; COST OF ILLNESS; DIABETES MELLITUS; DRUG COSTS; DRUG THERAPY, COMBINATION; FEMALE; HEART DISEASES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; STROKE; SURVIVAL RATE; TICLOPIDINE; TREATMENT OUTCOME;

EID: 60749134444     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2008.08.005     Document Type: Article

References (50)

1. Warlow C., Sudlow C., Dennis M., et al. Stroke. Lancet 362 (2003) 2121-2122
2. Naidech A.M., and Weisberg L.A. Treatment of chronic hypertension for the prevention of stroke. South Med J 96 (2003) 359-362
3. Ingall T.J. Preventing ischemic stroke. Current approaches to primary and secondary prevention. Postgrad Med 107 (2000) 34-36 39-42, 47-50
4. Caplan L.R. Now is an exciting time to care for stroke patients. South Med J 96 (2003) 329-330
5. Smith W.S., Hauser S.L., and Easton J.D. Cerebrovascular diseases. In: Braunwald E., Hauser S., and Fauci A.S. (Eds). Harrison's principles of internal medicine. 15th edition (2001), McGraw-Hill, New York
6. Straus S.E., Majumdar S.R., and McAlister F.A. New evidence for stroke prevention: Scientific review. JAMA 288 (2002) 1388-1395
7. Petty G.W., Brown Jr. R.D., Whisnant J.P., et al. Ischemic stroke subtypes: A population-based study of functional outcome, survival, and recurrence. Stroke 31 (2000) 1062-1068
8. Woo D., Gebel J., Miller R., et al. Incidence rates of first-ever ischemic stroke subtypes among blacks: A population-based study. Stroke 30 (1999) 2517-2522
9. Gorelick P.B., Sacco R.L., Smith D.B., et al. Prevention of a first stroke: A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 281 (1999) 1112-1120 Review
10. Dromerick A., and Reding M. Medical and neurological complications during inpatient stroke rehabilitation. Stroke 25 (1994) 358-361
11. Dobkin B.H. Neuromedical complications in stroke patients transferred for rehabilitation before and after diagnostic related groups. J Neurol Rehab 1 (1987) 3-7
12. McClatchie G. Survey of the rehabilitation outcomes of stroke. Med J Aust 1 (1980) 649-651
13. Bamford J., Dennis M., Sandercock P., et al. The frequency, causes and timing of death within 30 days of a first stroke: The Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry 53 (1990) 824-829
14. Brown M., and Glassenberg M. Mortality factors in patients with acute stroke. JAMA 224 (1973) 1493-1495
15. Viitanen M., Winblad B., and Asplund K. Autopsy-verified causes of death after stroke. Acta Med Scand 222 (1987) 401-408
16. Derouesne C., Cambon H., Yelnik A., et al. Infarcts in the middle cerebral artery territory: Pathological study of the mechanisms of death. Acta Neurol Scand 87 (1993) 361-366
17. Silver F.L., Norris J.W., Lewis A.J., et al. Early mortality following stroke: A prospective review. Stroke 15 (1984) 492-496
18. Doshi V.S., Say J.H., Young S.H., et al. Complications in stroke patients: A study carried out at the rehabilitation medicine service, Changi General Hospital. Singapore Med J 44 (2003) 643-652
19. McLean D.E. Medical complications experienced by a cohort of stroke survivors during inpatient, tertiary-level stroke rehabilitation. Arch Phys Med Rehabil 85 (2004) 466-469
20. Stroke Unit Trialists' Collaboration. A systematic review of specialist multidisciplinary team (stroke unit) care for stroke inpatients. In: Warlow C., Van Gijn J., and Sandercock P. (Eds). Stroke Module of The Cochrane Database of Systematic Reviews (1995), BMJ Publishing Group, London, England:
21. Roth E.J., Lovell L., Harvey R.L., et al. Stroke rehabilitation: Indwelling urinary catheters, enteral feeding tubes, and tracheostomies are associated with resource use and functional outcomes. Stroke 33 (2002) 1845-1850
22. Kennedy F.B., Pozen T.J., Gabelman E.H., et al. Stroke intensive care: An appraisal. Am Heart J 80 (1970) 188-196
23. Stevens R.S., Ambler N.R., and Warren M.D. A randomized controlled trial of a stroke rehabilitation ward. Age Ageing 13 (1984) 65-75
24. Adler M., Hamaty D., Brown C.C., et al. Medical audit of stroke rehabilitation: A critique of medical care review. J Chron Dis 30 (1977) 461-471
25. Kalra L., Yu G., Wilson K., et al. Medical complications during stroke rehabilitation. Stroke 26 (1995) 990-994
26. Nyberg L., and Gustafson Y. Patient falls in stroke rehabilitation: A challenge to rehabilitation strategies. Stroke 26 (1995) 838-842
27. Reding M.J., Winter S.W., Hochrein S.A., et al. Urinary incontinence after unilateral hemispheric stroke: A neurologic-epidemiologic perspective. J Neurol Rehab 1 (1987) 25-30
28. DePippo K.L., Holas M.A., Reding M.J., et al. Dysphagia therapy following stroke: A controlled trial. Neurology 44 (1994) 1655-1660
29. Feibel J.H., and Springer C.J. Depression and failure to resume social activities after stroke. Arch Phys Med Rehabil 63 (1982) 276-277
30. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
31. Albers G.W., and Tijssen J.G. Antiplatelet therapy: New foundations for optimal treatment decisions. Neurology 53 7 Suppl. 4 (1999) S25-S31
32. Wolf P.A., Clagett G.P., Easton J.D., et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 30 (1999) 1991-1994
33. Gueyffier F., Boissel J.P., Boutitie F., et al. Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators. Stroke 28 (1997) 2557-2562
34. PATS Collaborating Group. Post-stroke antihypertensive treatment study. A preliminary result. Chin Med J (Engl) 108 (1995) 710-717
35. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 358 (2001) 1033-1041
36. Johnston K.C., Li J.Y., Lyden P.D., et al. Medical and neurological complications of ischemic stroke: Experience from the RANTTAS trial. RANTTAS Investigators. Stroke 29 (1998) 447-453
37. Felberg R.A., and Naidech A.M. The 5 Ps of acute ischemic stroke treatment: Parenchyma, pipes, perfusion, penumbra, and prevention of complications. South Med J 96 (2003) 336-342
38. Zweifler R.M. Management of acute stroke. South Med J 96 (2003) 380-385
39. Straus S.E., Majumdar S.R., and McAlister F.A. New evidence for stroke prevention: Scientific review. JAMA 288 (2002) 1388-1395 Review
40. Kelley R.E., and Minagar A. Cardioembolic stroke: An update. South Med J 96 (2003) 343-349 Review
41. Markesbery W. The central nervous system. In: Golden A., Powell D.E., and Jennings C.D. (Eds). Understanding human disease (1985), William & Wilkins, Baltimore Pathology
42. Lalouschek W., Lang W., and Mullner M. Vienna Stroke Study Group. Current strategies of secondary prevention after a cerebrovascular event: The Vienna stroke registry. Stroke 32 (2001) 2860-2866
43. Mayer T.O., and Biller J. Antiplatelet prescribing patterns for TIA and ischemic stroke: The Indiana University experience. J Neurol Sci 207 (2003) 5-10
44. Sacco R.L., Sivenius J., and Diener H.C. Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations. Arch Neurol 62 (2005) 403-408
45. Diener H.C., Cunha L., Forbes C., et al. European stroke prevention study 2: Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143 (1996) 1-13
46. Dewey H.M., Thrift A.G., Mihalopoulos C., et al. Cost of stroke in Australia from a societal perspective: Results from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 32 (2001) 2409-2416
47. Terent A., Marke L.A., Asplund K., et al. Costs of stroke in Sweden. A national perspective. Stroke 25 (1994) 2363-2369
48. Teng J., Mayo N.E., Latimer E., et al. Costs and caregiver consequences of early supported discharge for stroke patients. Stroke 34 (2003) 528-536
49. Kolominsky-Rabas P.L., Heuschmann P.U., Marschall D., et al. Lifetime cost of ischemic stroke in Germany: Results and national projections from a population-based stroke registry: The Erlangen Stroke Project. Stroke 37 (2006) 1179-1183
50. Evers S.M., Struijs J.N., Ament A.J., et al. International comparison of stroke cost studies. Stroke 35 (2004) 1209-1215